| 000 | 01552 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518000501.0 | ||
| 264 | 0 | _c20190425 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a1471-499X | ||
| 024 | 7 |
_a10.1016/j.molmed.2018.08.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOrabona, Ciriana | |
| 245 | 0 | 0 |
_aImmune Checkpoint Molecules, Personalized Immunotherapy, and Autoimmune Diabetes. _h[electronic resource] |
| 260 |
_bTrends in molecular medicine _c11 2018 |
||
| 300 |
_a931-941 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAutoimmune Diseases _ximmunology |
| 650 | 0 | 4 |
_aAutoimmunity _xdrug effects |
| 650 | 0 | 4 |
_aB7-H1 Antigen _xmetabolism |
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 |
_aCTLA-4 Antigen _xmetabolism |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmune Tolerance |
| 650 | 0 | 4 |
_aImmunomodulation _xdrug effects |
| 650 | 0 | 4 |
_aImmunotherapy _xadverse effects |
| 650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
| 650 | 0 | 4 |
_aPrecision Medicine _xmethods |
| 650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMondanelli, Giada | |
| 700 | 1 | _aPuccetti, Paolo | |
| 700 | 1 | _aGrohmann, Ursula | |
| 773 | 0 |
_tTrends in molecular medicine _gvol. 24 _gno. 11 _gp. 931-941 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.molmed.2018.08.005 _zAvailable from publisher's website |
| 999 |
_c28856251 _d28856251 |
||